W. Dornoff

1.2k total citations
15 papers, 688 citations indexed

About

W. Dornoff is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, W. Dornoff has authored 15 papers receiving a total of 688 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 7 papers in Surgery and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in W. Dornoff's work include Bone health and treatments (6 papers), Estrogen and related hormone effects (3 papers) and Radiopharmaceutical Chemistry and Applications (3 papers). W. Dornoff is often cited by papers focused on Bone health and treatments (6 papers), Estrogen and related hormone effects (3 papers) and Radiopharmaceutical Chemistry and Applications (3 papers). W. Dornoff collaborates with scholars based in Germany, Switzerland and Finland. W. Dornoff's co-authors include Ingo Diel, М. Р. Личиницер, E.D. Kreuser, B. Bergström, M. Budde, Jean‐Jacques Body, В. А. Горбунова, P. Drings, Bengt Bergman and Kari Liippo and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and The Journal of Urology.

In The Last Decade

W. Dornoff

14 papers receiving 654 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
W. Dornoff Germany 9 569 259 202 192 126 15 688
Leo V. Lacerna United States 10 734 1.3× 254 1.0× 200 1.0× 78 0.4× 361 2.9× 13 802
Richard Leff United States 9 529 0.9× 190 0.7× 228 1.1× 158 0.8× 72 0.6× 14 659
Narciso Hernández Toriz Mexico 4 596 1.0× 353 1.4× 168 0.8× 100 0.5× 337 2.7× 6 799
Amy Kupic United States 3 603 1.1× 347 1.3× 175 0.9× 101 0.5× 337 2.7× 5 798
T. Taube Finland 12 515 0.9× 162 0.6× 201 1.0× 87 0.5× 119 0.9× 15 620
A Fontana France 10 324 0.6× 89 0.3× 106 0.5× 58 0.3× 128 1.0× 25 505
Lixian Jin United States 8 493 0.9× 118 0.5× 195 1.0× 72 0.4× 197 1.6× 15 559
Yong Jiang Hei United States 4 531 0.9× 295 1.1× 287 1.4× 77 0.4× 100 0.8× 7 578
Lea Latham Italy 9 163 0.3× 173 0.7× 59 0.3× 60 0.3× 66 0.5× 17 401
Viktor Wette Austria 9 406 0.7× 114 0.4× 38 0.2× 55 0.3× 54 0.4× 12 540

Countries citing papers authored by W. Dornoff

Since Specialization
Citations

This map shows the geographic impact of W. Dornoff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. Dornoff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. Dornoff more than expected).

Fields of papers citing papers by W. Dornoff

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W. Dornoff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. Dornoff. The network helps show where W. Dornoff may publish in the future.

Co-authorship network of co-authors of W. Dornoff

This figure shows the co-authorship network connecting the top 25 collaborators of W. Dornoff. A scholar is included among the top collaborators of W. Dornoff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W. Dornoff. W. Dornoff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
2.
Hadji, Peyman, M. Ziller, W. Dornoff, et al.. (2009). Bone effects of exemestane vs. tamoxifen within the TEAM trial: results of a prospective randomized bone sub study.. Cancer Research. 69(2_Supplement). 1143–1143. 2 indexed citations
3.
Ziller, M., et al.. (2008). Bone effects of exemestane versus tamoxifen within the TEAM Trial: Results of a prospective randomized bone substudy. Journal of Clinical Oncology. 26(15_suppl). 572–572. 1 indexed citations
4.
Diel, Ingo, Jean‐Jacques Body, М. Р. Личиницер, et al.. (2004). Improved quality of life after long-term treatment with the bisphosphonate ibandronate in patients with metastatic bone disease due to breast cancer. European Journal of Cancer. 40(11). 1704–1712. 112 indexed citations
5.
Body, Jean‐Jacques, Ingo Diel, М. Р. Личиницер, et al.. (2003). Intravenous ibandronate reduces the incidence of skeletal complications in patients with breast cancer and bone metastases. Annals of Oncology. 14(9). 1399–1405. 296 indexed citations
6.
7.
8.
Diel, Ingo, М. Р. Личиницер, J.J. Body, et al.. (1999). Improvement of bone pain, quality of life and survival time of breast cancer patients with metastatic bone disease treated with intravenous ibandronate. European Journal of Cancer. 35. S83–S83. 12 indexed citations
9.
10.
Schmidberger, Heinz, M. Bamberg, Christoph Meisner, et al.. (1998). Radiotherapy in Stage IIA and IIB Testicular Seminoma With Reduced Portals: A Prospective Multicenter Study. The Journal of Urology. 159(6). 2239–2239. 9 indexed citations
11.
Manegold, C., Bengt Bergman, A. Chemaissani, et al.. (1997). Single-agent gemcitabine versus cisplatin-etoposide: Early results of a randomised phase II study in locally advanced or metastatic non-small-cell lung cancer. Annals of Oncology. 8(6). 525–529. 91 indexed citations
12.
Schmidberger, Heinz, Michael Bamberg, C Meisner, et al.. (1997). Radiotherapy in stage IIA and IIB testicular seminoma with reduced portals: A prospective multicenter study. International Journal of Radiation Oncology*Biology*Physics. 39(2). 321–326. 39 indexed citations
13.
Manegold, C., P. Drings, Joachim von Pawel, et al.. (1997). A randomized study of gemcitabine monotherapy versus etoposide/cisplatin in the treatment of locally advanced or metastatic non-small cell lung cancer.. PubMed. 24(3 Suppl 8). S8–13. 9 indexed citations
14.
15.
Schwerdtfeger, F., W. Dornoff, & Jan Gosepath. (1990). Die primär kurative Strahlentherapie kleiner Stimmbandkarzinome. Laryngo-Rhino-Otologie. 69(6). 308–311. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Leo V. Lacerna Breakdown of academic impact, for papers by Richard Leff Breakdown of academic impact, for papers by Narciso Hernández Toriz Breakdown of academic impact, for papers by Amy Kupic Breakdown of academic impact, for papers by T. Taube Breakdown of academic impact, for papers by A Fontana Breakdown of academic impact, for papers by Lixian Jin Breakdown of academic impact, for papers by Yong Jiang Hei Breakdown of academic impact, for papers by Lea Latham Breakdown of academic impact, for papers by Viktor Wette
Rankless by CCL
2026